New radiologic classification of renal angiomyolipoma: frequently asked questions

Sung Goo Park; Byung Kwan Park

doi:10.1016/j.clinimag.2019.01.025

New radiologic classification of renal angiomyolipoma: frequently asked questions

Sung Goo Park
, Byung Kwan Park

Department of Radiology

Sungkyunkwan University

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Recently, a new classification of renal angiomyolipoma (AML) has been introduced to clinical practice. This classification categorizes AMLs into three subtypes (fat-rich, fat-poor, and fat-invisible AMLs) based on quantitative CT and MRI criteria. Radiologists who get used to previous AML classification may have questions about how to apply a new classification. The purpose of this review is to answer the questions that are frequently asked about the new AML classification.

Original language	English
Pages (from-to)	156-160
Number of pages	5
Journal	Clinical Imaging
Volume	55
DOIs	https://doi.org/10.1016/j.clinimag.2019.01.025
State	Published - 1 May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Angiomyolipoma
Carcinoma, renal cell
Kidney
Magnetic resonance imaging
Multidetector computed tomography

Access to Document

10.1016/j.clinimag.2019.01.025

Cite this

@article{22c773c4bec14e5f80dd43f7f2f2dad3,

title = "New radiologic classification of renal angiomyolipoma: frequently asked questions",

abstract = "Recently, a new classification of renal angiomyolipoma (AML) has been introduced to clinical practice. This classification categorizes AMLs into three subtypes (fat-rich, fat-poor, and fat-invisible AMLs) based on quantitative CT and MRI criteria. Radiologists who get used to previous AML classification may have questions about how to apply a new classification. The purpose of this review is to answer the questions that are frequently asked about the new AML classification.",

keywords = "Angiomyolipoma, Carcinoma, renal cell, Kidney, Magnetic resonance imaging, Multidetector computed tomography",

author = "Park, \{Sung Goo\} and Park, \{Byung Kwan\}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = may,

day = "1",

doi = "10.1016/j.clinimag.2019.01.025",

language = "English",

volume = "55",

pages = "156--160",

journal = "Clinical Imaging",

issn = "0899-7071",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - New radiologic classification of renal angiomyolipoma

T2 - frequently asked questions

AU - Park, Sung Goo

AU - Park, Byung Kwan

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Recently, a new classification of renal angiomyolipoma (AML) has been introduced to clinical practice. This classification categorizes AMLs into three subtypes (fat-rich, fat-poor, and fat-invisible AMLs) based on quantitative CT and MRI criteria. Radiologists who get used to previous AML classification may have questions about how to apply a new classification. The purpose of this review is to answer the questions that are frequently asked about the new AML classification.

AB - Recently, a new classification of renal angiomyolipoma (AML) has been introduced to clinical practice. This classification categorizes AMLs into three subtypes (fat-rich, fat-poor, and fat-invisible AMLs) based on quantitative CT and MRI criteria. Radiologists who get used to previous AML classification may have questions about how to apply a new classification. The purpose of this review is to answer the questions that are frequently asked about the new AML classification.

KW - Angiomyolipoma

KW - Carcinoma, renal cell

KW - Kidney

KW - Magnetic resonance imaging

KW - Multidetector computed tomography

UR - https://www.scopus.com/pages/publications/85062023597

U2 - 10.1016/j.clinimag.2019.01.025

DO - 10.1016/j.clinimag.2019.01.025

M3 - Review article

C2 - 30825810

AN - SCOPUS:85062023597

SN - 0899-7071

VL - 55

SP - 156

EP - 160

JO - Clinical Imaging

JF - Clinical Imaging

ER -

New radiologic classification of renal angiomyolipoma: frequently asked questions

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this